Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Singular Genomics Systems, Inc. (OMIC : NSDQ)
 
 • Company Description   
Singular Genomics Systems Inc. is a life science technology company. It focused on delivering genomic technologies for the advancement of science and medicine. Singular Genomics Systems Inc. is based in LA JOLLA, Calif.

Number of Employees: 221

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.99 Daily Weekly Monthly
20 Day Moving Average: 470,409 shares
Shares Outstanding: 70.58 (millions)
Market Capitalization: $211.05 (millions)
Beta:
52 Week High: $33.37
52 Week Low: $2.87
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -33.85% -29.93%
12 Week -62.95% -59.52%
Year To Date -74.14% -68.72%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3010 Science Park Road
-
SAN DIEGO,CA 92121
USA
ph: 858-333-7830
fax: -
None http://singulargenomics.com
 
 • General Corporate Information   
Officers
Andrew Spaventa - Chief Executive Officer and Chair of the Board
Dalen Meeter - Senior Vice President; Finance
Michael Pellini - Lead Independent Director
David Barker - Director
Kim Kamdar - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 82933R100
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
Share - Related Items
Shares Outstanding: 70.58
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $211.05 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.34 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.37 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 18.52% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.68
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -14.81%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -21.29
12/31/21 - -30.55
09/30/21 - -42.53
ROA
03/31/22 - -20.12
12/31/21 - -23.69
09/30/21 - -26.83
Current Ratio
03/31/22 - 35.87
12/31/21 - 51.57
09/30/21 - 60.80
Quick Ratio
03/31/22 - 35.18
12/31/21 - 51.57
09/30/21 - 60.80
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - 4.50
12/31/21 - 4.67
09/30/21 - 4.92
Inventory Turnover
03/31/22 - 0.00
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.03
12/31/21 - 0.03
09/30/21 - 0.03
Debt-to-Capital
03/31/22 - 3.04
12/31/21 - 2.86
09/30/21 - 2.73
 

Powered by Zacks Investment Research ©